Kakajan Komurov
Chief Scientific and Technology Officer Corellia AI
Seminars
Thursday 30th July 2026
Enabling Targeted Inhibition of Oncogenic Kinases Through Linker Design
8:30 am
- Exploring how Kinase Inhibitor payloads have the potential to overcome the on-target toxicities of systemic treatment while providing tumor selectivity for cytotoxicity
- Designing proper linker & spacer constructs to enable high DAR conjugation that is stable and cleavage amenable
